Omeros Corporation
NASDAQ:OMERBiotechnology
+$0.43 today
- Market cap
- $1.08B
- Beta
- 2.53
- P/E (TTM)
- 8.4
- EPS (TTM)
- $1.20
Volume 2.53M
Average 1.55M
OMER Other Working Capital
Cash effect of changes in other operating assets and liabilities.
Omeros CorporationNASDAQ: OMER
Other Working Capital · Q1 FY2026 · quarter ended Mar 2026
Other working capital turns positive
Q1 FY2026 other working capital was $87K, compared with -$472K a year earlier. Trailing-twelve-month other working capital was $8.81M. Over 3 fiscal years it compounded at -63.4% a year.
Context
- Other working capital increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly other working capital holds near $87K or moves back toward the trailing-twelve-month quarterly average of $2.2M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Working Capital history
USD · from the cash flow
- Latest · FY2025
- 3.27M USD
- Year-over-year change
- +131.9%
- 4-year CAGR
- -12.5%
| Period | Period end | Other Working Capital | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.27M | +131.9% |
| FY2024 | 2024-12-31 | (10.27M) | -702.5% |
| FY2023 | 2023-12-31 | 1.7M | -97.4% |
| FY2022 | 2022-12-31 | 66.76M | +1099.0% |
| FY2021 | 2021-12-31 | 5.57M | — |
Other Working Capital vs competitors
How OMER compares with its peers on the latest reported figures
- OMER's LTM Mar 2026 other working capital of $8.81M is the 7th largest of the 11 companies compared; the peer median is $958.5K.
- Its year-over-year change of +143.5% is the 5th highest of 10, against a peer median of +105.0%.
- Other working capital amounts to 89.0% of revenue for OMER, versus a peer median of 16.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $104M | -23.0% | +36.6% | 88.9% | |
| LTM Jun 2026 | $90.58M | +323.8% | +32.3% | 165.9% | |
| LTM Jun 2026 | $41.72M | -258.5% | — | — | |
| LTM Jun 2026 | $17.17M | -46.5% | +12.5% | 16.4% | |
| LTM Mar 2026 | $15.61M | -279.8% | — | 9.9% | |
| LTM Mar 2026 | $13.47M | +234.3% | +8.5% | — | |
| LTM Mar 2026 | $8.81M | +143.5% | -63.4% | 89.0% | |
| LTM Mar 2026 | $1.92M | +150.9% | -48.7% | 0.8% | |
| LTM Mar 2026 | $562.58K | +511.5% | — | 112.5% | |
| LTM Mar 2026 | $59K | +105.0% | +49.7% | — | |
| LTM Dec 2025 | $0 | — | -3.8% | 0.0% | |
| Peer median (excluding OMER) | $958.5K | +105.0% | +12.5% | 16.4% | |
Competitors are the stored peer set for OMER. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (191.55M) | (182.03M) | (117.81M) | (156.82M) | (3.35M) |
| Depreciation & Amortization | 1.39M | 952K | 920K | 950K | 964K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 11.65M | 10.49M | 8.19M |
| Change in Working Capital | (14.11M) | (118.97M) | 247.42M | 29.74M | 33.72M |
| Accounts Receivables | (34.31M) | (175.07M) | 245.72M | 40.01M | 30.45M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 14.64M | (10.67M) | 0 | 0 | 0 |
| Other Working Capital | 5.57M | 66.76M | 1.7M | (10.27M) | 3.27M |
| Other Non-Cash Items | 94.54M | 213.56M | (67.46M) | (33.17M) | (155.62M) |
| Operating Cash Flow | (109.72M) | (86.48M) | 74.73M | (148.8M) | (116.09M) |
| Capital Expenditures | (277K) | (113K) | (426K) | (165K) | (65K) |
| Acquisitions (Net) | 125.99M | 0 | 0 | 0 | 0 |
| Purchases of Investments | (32.01M) | (429.05M) | (1.02B) | (987.39M) | (185.31M) |
| Sales of Investments | 100M | 301.59M | 1.05B | 1.07B | 109.9M |
| Other Investing Activities | 0 | 0 | 0 | 0 | 240M |
| Investing Cash Flow | 193.71M | (127.56M) | 27.45M | 82.22M | 164.52M |
| Debt Repayment | (1.82M) | 123.83M | (101.58M) | (41.34M) | (89.16M) |
| Common Stock Issued | 8.38M | 415K | 0 | 0 | 46.99M |
| Common Stock Repurchased | 0 | 0 | (4.65M) | (11.85M) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (241K) | 0 | 150K | 116.07M | 0 |
| Financing Cash Flow | 6.32M | 124.25M | (106.08M) | 62.88M | (42.17M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 90.31M | (89.8M) | (3.9M) | (3.71M) | 6.26M |
| Free Cash Flow | (110M) | (86.6M) | 74.3M | (148.97M) | (116.16M) |
Omeros Corporation
NASDAQ:OMER
Intrinsic Alpha fair value
Locked
Current Price
$14.55
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.